Skip to main content
. 2008 Apr 29;98(9):1562–1569. doi: 10.1038/sj.bjc.6604340

Table 3. Sensitivity, specificity and false-positive rate of anti-EMA antibodies assessed by immunocytology on confirmed mesothelioma effusions and cases of benign reactive effusions.

Anti-EMA clone Sensitivity Specificity False positives
VU2G7 5/20 (25%) 16/16 (100%) 0%
VU4H5 5/20 (25%) 16/16 (100%) 0%
CBL263 (VU3C6) 6/19 (32%) 15/15 (100%) 0%
MA552 9/18 (50%) 12/13 (92%) 0%
MA695 14/20 (70%) 5/15 (33%) 0%
E29 16/19 (84%) 14/15 (93%) 0%
Mc5 20/20 (100%) 0/14 (0%) 8/14 (57%)